Berenberg Bank set a €114.00 ($132.56) price target on Carl Zeiss Meditec (ETR:AFX) in a report released on Thursday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

A number of other research firms have also recently weighed in on AFX. Nord/LB set a €132.00 ($153.49) price target on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research note on Wednesday, December 11th. Independent Research set a €93.00 ($108.14) price target on shares of Carl Zeiss Meditec and gave the stock a sell rating in a research note on Tuesday, December 10th. Deutsche Bank set a €123.00 ($143.02) price target on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research note on Monday, December 9th. HSBC set a €109.00 ($126.74) price objective on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Tuesday, December 10th. Finally, Hauck & Aufhaeuser set a €110.00 ($127.91) price objective on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research report on Thursday, October 24th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company. The company has an average rating of Hold and a consensus target price of €111.14 ($129.24).

AFX traded up €1.40 ($1.63) during trading on Thursday, hitting €120.20 ($139.77). The stock had a trading volume of 102,713 shares, compared to its average volume of 94,405. The company has a debt-to-equity ratio of 4.06, a quick ratio of 3.01 and a current ratio of 3.84. Carl Zeiss Meditec has a twelve month low of €71.25 ($82.85) and a twelve month high of €121.10 ($140.81). The firm has a market capitalization of $10.75 billion and a P/E ratio of 67.30. The company’s 50-day moving average price is €114.92 and its 200 day moving average price is €104.10.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Featured Article: Diversification Important in Investing

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.